A Combination of Plerixafor and Filgrasting Promotes Successful CD34+ Cell Collection for CRISPR/Cas9 Therapy in Sickle Cell Disease Patients With Insufficient Response to Plerixafor Alone.

Arcioni F;Bonetti M;Sau A;Zecca M;Alzahrani M;Alahmari B;Alsadi H;Almozaini A;Ahmed M;Essa M;Perotti C;Del Fante C;Passeri C;Iuliani O;Russo AC;Di Ianni M;Marchesi M;Pasqua BL;Onorato M;Berchicci L;Pierini A;Zei T;Iacucci R;Cerri C;Gurdo G;Innocente A;Capolsini I;Gorello P;Colombatti R;Origa R

Penultimo

;Caniglia M.

2026-01-01